This is consistent with the increased levels of CXCL1, CXCL8, and CCL2 in induced sputum and/or BAL fluid [109] and the augmented levels of CCL18 in the serum of COPD patients [126]. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.